<DOC>
	<DOCNO>NCT02157714</DOCNO>
	<brief_summary>This multiple ascend dose study determine safety , tolerability , pharmacokinetics immunogenicity PRX002 approximately 60 patient Parkinson 's disease .</brief_summary>
	<brief_title>Multiple Ascending Dose Study PRX002 Patients With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's disease , Hoehn Yahr 13 Body weight range ≥ 45kg/99 lbs ≤ 110 kg/242 lbs Female subject must surgically sterile postmenopausal childbearing potential must use contraception Male subject partner childbearing potential must use contraception Significant cardiac history Abnormal MRI Significant laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>